title: Clinical utility of HIV standard genotyping among antiretroviral-naive individuals with unknown duration of infection.
abstract: In clinical settings, we have found a high rate of human immunodeficiency virus (HIV) drug resistance among antiretroviral-naive patients for whom the duration of infection was unknown. These high rates were most likely the result of both transmitted resistance and informal antiretroviral use, and they suggest that routine resistance testing among antiretroviral-naive patients would be a cost-effective clinical practice.
authors.affiliation: University of California San Diego, San Diego, CA 92103, USA. davey@ucsd.edu
authors.forename: Davey
authors.initials: D
authors.lastname: Smith
authors.forename: Niousha
authors.initials: N
authors.lastname: Moini
authors.forename: Rick
authors.initials: R
authors.lastname: Pesano
authors.forename: Edward
authors.initials: E
authors.lastname: Cachay
authors.forename: Heidi
authors.initials: H
authors.lastname: Aiem
authors.forename: Yolanda
authors.initials: Y
authors.lastname: Lie
authors.forename: Douglas
authors.initials: D
authors.lastname: Richman
authors.forename: Susan
authors.initials: S
authors.lastname: Little
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology*; D002140:California / Q000453:epidemiology; D024921:Drug Resistance, Multiple, Viral / Q000187:drug effects / Q000235:genetics*; D005260:Female; D005838:Genotype; D006678:HIV / Q000187:drug effects* / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D008297:Male; D010347:Patient Care Planning; D015995:Prevalence; D016896:Treatment Outcome
chemical_list: D019380:Anti-HIV Agents